Top Markets
Coin of the day
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Rangering i aksjer #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Aksjekurs
$0.00060315
Sist synkronisert: 2024-09-27
Markedsverdi
$1.65M
Endring (1 dag)
19.64%
Endring (1 år)
0.00%
Land
SE
Handel Amniotics AB (publ) (AMNI)

Kategori

EPS for Amniotics AB (publ) (AMNI)
EPS per December 2023 TTM: $-0.04
Ifølge de siste økonomiske rapportene og aksjekursen til Amniotics AB (publ) er selskapets nåværende EPS (TTM) $-0.04. Ved slutten av 2022 hadde selskapet en EPS på $-0.03, en nedgang sammenlignet med EPS-en i 2021 som var $-0.04.
EPS-historikk for Amniotics AB (publ) fra 2018 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) $-0.04 -96.18%
2023 0.00 -96.18%
2022 $-0.03 -21.10%
2021 $-0.04 77.18%
2020 $-0.02 237.70%
2019 $-0.01 45.24%
2018 0.00 0.00%
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$17.32 -47,293.46%
US
$27.74 -75,685.83%
NL
- -
CH
- -
KR
$13.70 -37,429.97%
BE